Previous Article | Next Article 
Molecular and Cellular Biology, June 2004, p. 5157-5171, Vol. 24, No. 12
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.12.5157-5171.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
ACTR/AIB1 Functions as an E2F1 Coactivator To Promote Breast Cancer Cell Proliferation and Antiestrogen Resistance
Maggie C. Louie, June X. Zou, Alina Rabinovich, and Hong-Wu Chen*
Department of Biological Chemistry, School of Medicine, UCD Cancer Center/Basic Science, University of California at Davis, Sacramento, California 95817
Received 6 January 2004/
Returned for modification 3 February 2004/
Accepted 24 March 2004
Overexpression or amplification of ACTR (also named AIB1, RAC3, p/CIP, TRAM-1, and SRC-3), a member of the p160 family of coactivators for nuclear hormone receptors, has been frequently detected in multiple types of human tumors, including breast cancer. However, its role in cancer cell proliferation and the underlying mechanism are unclear. Here, we show that overexpression of ACTR not only enhances estrogen-stimulated cell proliferation but also, more strikingly, completely negates the cell cycle arrest effect by tamoxifen and pure antiestrogens. Unexpectedly, we found that ACTR directly interacts, through its N-terminal domain, with E2F1 and is recruited to E2F target gene promoters. Elevation of ACTR in quiescent cells strongly stimulates the transcription of a subset of E2F-responsive genes that are associated with the G1/S transition. We also demonstrated, by adenovirus vector-mediated RNA interference, that ACTR is required for E2F1-mediated gene expression and the proliferation of estrogen receptor (ER)-negative breast cancer cells. Moreover, the ability of elevated ACTR to promote estrogen-independent cell proliferation depends on the function of E2F1 and the association between ACTR and E2F1, but not ER. Thus, our results reveal an essential role of ACTR in control of breast cancer cell proliferation and implicate the ACTR-E2F1 pathway as a novel mechanism in antiestrogen resistance.
* Corresponding author. Mailing address: Department of Biological Chemistry, School of Medicine, UCD Cancer Center/Basic Science, University of California at Davis, UCDMC Res III, Rm. 1400B, 4645 2nd Ave., Sacramento, CA 95817. Phone: (916) 734-7743. Fax: (916) 734-0190. E-mail:
hwzchen{at}ucdavis.edu.
Molecular and Cellular Biology, June 2004, p. 5157-5171, Vol. 24, No. 12
0022-538X/04/$08.00+0 DOI: 10.1128/MCB.24.12.5157-5171.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Alkner, S., Bendahl, P.-O., Grabau, D., Lovgren, K., Stal, O., Ryden, L., Ferno, M., on behalf of the South Swedish and South-East Swed,
(2009). AIB1 is a predictive factor for tamoxifen response in premenopausal women. Ann Oncol
0: mdp293v1-mdp293
[Abstract]
[Full Text]
-
Khoshnaw, S M, Green, A R, Powe, D G, Ellis, I O
(2009). MicroRNA involvement in the pathogenesis and management of breast cancer. J. Clin. Pathol.
62: 422-428
[Abstract]
[Full Text]
-
Zhang, Y., Zhao, H., Asztalos, S., Chisamore, M., Sitabkhan, Y., Tonetti, D. A.
(2009). Estradiol-Induced Regression in T47D:A18/PKC{alpha} Tumors Requires the Estrogen Receptor and Interaction with the Extracellular Matrix. Mol Cancer Res
7: 498-510
[Abstract]
[Full Text]
-
Karmakar, S., Foster, E. A., Smith, C. L.
(2009). Unique Roles of p160 Coactivators for Regulation of Breast Cancer Cell Proliferation and Estrogen Receptor-{alpha} Transcriptional Activity. Endocrinology
150: 1588-1596
[Abstract]
[Full Text]
-
Bartels, C. L., Tsongalis, G. J.
(2009). MicroRNAs: Novel Biomarkers for Human Cancer. Clin. Chem.
55: 623-631
[Abstract]
[Full Text]
-
Wang, S., Yuan, Y., Liao, L., Kuang, S.-Q., Tien, J. C.-Y., O'Malley, B. W., Xu, J.
(2009). Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc. Natl. Acad. Sci. USA
106: 151-156
[Abstract]
[Full Text]
-
Oh, A. S., Lahusen, J. T., Chien, C. D., Fereshteh, M. P., Zhang, X., Dakshanamurthy, S., Xu, J., Kagan, B. L., Wellstein, A., Riegel, A. T.
(2008). Tyrosine Phosphorylation of the Nuclear Receptor Coactivator AIB1/SRC-3 Is Enhanced by Abl Kinase and Is Required for Its Activity in Cancer Cells. Mol. Cell. Biol.
28: 6580-6593
[Abstract]
[Full Text]
-
Ferrero, M., Avivar, A., Garcia-Macias, M. C., de Mora, J. F.
(2008). Phosphoinositide 3-kinase/AKT Signaling Can Promote AIB1 Stability Independently of GSK3 Phosphorylation. Cancer Res.
68: 5450-5459
[Abstract]
[Full Text]
-
Yan, J., Erdem, H., Li, R., Cai, Y., Ayala, G., Ittmann, M., Yu-Lee, L.-y., Tsai, S. Y., Tsai, M.-J.
(2008). Steroid Receptor Coactivator-3/AIB1 Promotes Cell Migration and Invasiveness through Focal Adhesion Turnover and Matrix Metalloproteinase Expression. Cancer Res.
68: 5460-5468
[Abstract]
[Full Text]
-
Fereshteh, M. P., Tilli, M. T., Kim, S. E., Xu, J., O'Malley, B. W., Wellstein, A., Furth, P. A., Riegel, A. T.
(2008). The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice. Cancer Res.
68: 3697-3706
[Abstract]
[Full Text]
-
Frietze, S., Lupien, M., Silver, P. A., Brown, M.
(2008). CARM1 Regulates Estrogen-Stimulated Breast Cancer Growth through Up-regulation of E2F1. Cancer Res.
68: 301-306
[Abstract]
[Full Text]
-
Zou, J. X., Revenko, A. S., Li, L. B., Gemo, A. T., Chen, H.-W.
(2007). ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ER{alpha}, is required for coregulator occupancy and chromatin modification. Proc. Natl. Acad. Sci. USA
104: 18067-18072
[Abstract]
[Full Text]
-
Amazit, L., Pasini, L., Szafran, A. T., Berno, V., Wu, R.-C., Mielke, M., Jones, E. D., Mancini, M. G., Hinojos, C. A., O'Malley, B. W., Mancini, M. A.
(2007). Regulation of SRC-3 Intercompartmental Dynamics by Estrogen Receptor and Phosphorylation. Mol. Cell. Biol.
27: 6913-6932
[Abstract]
[Full Text]
-
Yuan, Y., Qin, L., Liu, D., Wu, R.-C., Mussi, P., Zhou, S., Songyang, Z., Xu, J.
(2007). Genetic Screening Reveals an Essential Role of p27kip1 in Restriction of Breast Cancer Progression. Cancer Res.
67: 8032-8042
[Abstract]
[Full Text]
-
Lahusen, T., Fereshteh, M., Oh, A., Wellstein, A., Riegel, A. T.
(2007). Epidermal Growth Factor Receptor Tyrosine Phosphorylation and Signaling Controlled by a Nuclear Receptor Coactivator, Amplified in Breast Cancer 1. Cancer Res.
67: 7256-7265
[Abstract]
[Full Text]
-
Chung, A. C-K., Zhou, S., Liao, L., Tien, J. C.-Y., Greenberg, N. M., Xu, J.
(2007). Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice. Cancer Res.
67: 5965-5975
[Abstract]
[Full Text]
-
Cao, Z., Wu, X., Yen, L., Sweeney, C., Carraway, K. L. III
(2007). Neuregulin-Induced ErbB3 Downregulation Is Mediated by a Protein Stability Cascade Involving the E3 Ubiquitin Ligase Nrdp1. Mol. Cell. Biol.
27: 2180-2188
[Abstract]
[Full Text]
-
Li, H. J., Haque, Z., Lu, Q., Li, L., Karas, R., Mendelsohn, M.
(2007). Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation. Proc. Natl. Acad. Sci. USA
104: 4065-4070
[Abstract]
[Full Text]
-
Mussi, P., Yu, C., O'Malley, B. W., Xu, J.
(2006). Stimulation of Steroid Receptor Coactivator-3 (SRC-3) Gene Overexpression by a Positive Regulatory Loop of E2F1 and SRC-3. Mol. Endocrinol.
20: 3105-3119
[Abstract]
[Full Text]
-
Yan, J., Yu, C.-T., Ozen, M., Ittmann, M., Tsai, S. Y., Tsai, M.-J.
(2006). Steroid Receptor Coactivator-3 and Activator Protein-1 Coordinately Regulate the Transcription of Components of the Insulin-Like Growth Factor/AKT Signaling Pathway.. Cancer Res.
66: 11039-11046
[Abstract]
[Full Text]
-
Hossain, A., Kuo, M. T., Saunders, G. F.
(2006). Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA. Mol. Cell. Biol.
26: 8191-8201
[Abstract]
[Full Text]
-
Desai, S. J., Ma, A.-H., Tepper, C. G., Chen, H.-W., Kung, H.-J.
(2006). Inappropriate Activation of the Androgen Receptor by Nonsteroids: Involvement of the Src Kinase Pathway and Its Therapeutic Implications. Cancer Res.
66: 10449-10459
[Abstract]
[Full Text]
-
Riggs, K. A., Wickramasinghe, N. S., Cochrum, R. K., Watts, M. B., Klinge, C. M.
(2006). Decreased Chicken Ovalbumin Upstream Promoter Transcription Factor II Expression in Tamoxifen-Resistant Breast Cancer Cells.. Cancer Res.
66: 10188-10198
[Abstract]
[Full Text]
-
El Messaoudi, S., Fabbrizio, E., Rodriguez, C., Chuchana, P., Fauquier, L., Cheng, D., Theillet, C., Vandel, L., Bedford, M. T., Sardet, C.
(2006). Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. Proc. Natl. Acad. Sci. USA
103: 13351-13356
[Abstract]
[Full Text]
-
Ma, A.-H., Xia, L., Desai, S. J., Boucher, D. L., Guan, Y., Shih, H.-M., Shi, X.-B., deVere White, R. W., Chen, H.-W., Tepper, C. G., Kung, H.-J.
(2006). Male Germ Cell-Associated Kinase, a Male-Specific Kinase Regulated by Androgen, Is a Coactivator of Androgen Receptor in Prostate Cancer Cells.. Cancer Res.
66: 8439-8447
[Abstract]
[Full Text]
-
Louie, M. C., Revenko, A. S., Zou, J. X., Yao, J., Chen, H.-W.
(2006). Direct Control of Cell Cycle Gene Expression by Proto-Oncogene Product ACTR, and Its Autoregulation Underlies Its Transforming Activity. Mol. Cell. Biol.
26: 3810-3823
[Abstract]
[Full Text]
-
Tu, Z., Prajapati, S., Park, K.-J., Kelly, N. J., Yamamoto, Y., Gaynor, R. B.
(2006). IKK{alpha} Regulates Estrogen-induced Cell Cycle Progression by Modulating E2F1 Expression. J. Biol. Chem.
281: 6699-6706
[Abstract]
[Full Text]
-
Yi, P., Wu, R.-C., Sandquist, J., Wong, J., Tsai, S. Y., Tsai, M.-J., Means, A. R., O'Malley, B. W.
(2005). Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1). Mol. Cell. Biol.
25: 9687-9699
[Abstract]
[Full Text]
-
Zheng, F. F., Wu, R.-C., Smith, C. L., O'Malley, B. W.
(2005). Rapid Estrogen-Induced Phosphorylation of the SRC-3 Coactivator Occurs in an Extranuclear Complex Containing Estrogen Receptor. Mol. Cell. Biol.
25: 8273-8284
[Abstract]
[Full Text]
-
Zhou, H.-J., Yan, J., Luo, W., Ayala, G., Lin, S.-H., Erdem, H., Ittmann, M., Tsai, S. Y., Tsai, M.-J.
(2005). SRC-3 Is Required for Prostate Cancer Cell Proliferation and Survival. Cancer Res.
65: 7976-7983
[Abstract]
[Full Text]
-
Wu, R.-C., Smith, C. L., O'Malley, B. W.
(2005). Transcriptional Regulation by Steroid Receptor Coactivator Phosphorylation. Endocr. Rev.
26: 393-399
[Abstract]
[Full Text]
-
Burwinkel, B., Wirtenberger, M., Klaes, R., Schmutzler, R. K., Grzybowska, E., Forsti, A., Frank, B., Bermejo, J. L., Bugert, P., Wappenschmidt, B., Butkiewicz, D., Pamula, J., Pekala, W., Zientek, H., Mielzynska, D., Siwinska, E., Bartram, C. R., Hemminki, K.
(2005). Association of NCOA3 Polymorphisms with Breast Cancer Risk. Clin. Cancer Res.
11: 2169-2174
[Abstract]
[Full Text]
-
Tilli, M. T., Reiter, R., Oh, A. S., Henke, R. T., McDonnell, K., Gallicano, G. I., Furth, P. A., Riegel, A. T.
(2005). Overexpression of an N-Terminally Truncated Isoform of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 Leads to Altered Proliferation of Mammary Epithelial Cells in Transgenic Mice. Mol. Endocrinol.
19: 644-656
[Abstract]
[Full Text]